Fig. 3From: Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitisKaplan–Meier curve for time to treatment discontinuation among patients initiating tofacitinib, by prior biologic historyBack to article page